Alzamend Neuro, Inc. SEC filings ALZN
Alzamend Neuro, Inc. has 397 filings in SEC EDGAR's recent list, going back to Jun 22, 2016. Its latest annual report, Form 10-K, was filed on Jul 22, 2026 for the period ended Apr 30, 2026. The latest quarterly report (Form 10-Q) was filed on Sep 10, 2026, covering the quarter ended Jul 31, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (regulation fd disclosure). The company's fiscal year ends on April 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-1 | Registration statement | Aug 21, 2026 | — |
| 424B5 | Prospectus supplement | Mar 6, 2026 | — |
| 424B3 | Prospectus | Apr 9, 2025 | — |
| S-1/A | Amended registration statement | Mar 27, 2025 | — |
| S-3 | Shelf registration | Mar 13, 2025 | — |
| 424B5 | Prospectus supplement | Oct 3, 2024 | — |
| 424B3 | Prospectus | Jul 10, 2024 | — |
| S-1/A | Amended registration statement | Jul 3, 2024 | — |
| S-1/A | Amended registration statement | Jun 26, 2024 | — |
| S-1 | Registration statement | Jun 3, 2024 | — |
| 424B5 | Prospectus supplement | May 10, 2024 | — |
| 424B5 | Prospectus supplement | May 7, 2024 | — |
| 424B5 | Prospectus supplement | Sep 8, 2023 | — |
| S-3 | Shelf registration | Aug 2, 2023 | — |
| S-8 | Employee stock plan registration | Jul 13, 2021 | — |
| 424B4 | Prospectus | Jun 15, 2021 | — |
| S-1/A | Amended registration statement | Jun 11, 2021 | — |
| FWP | Free writing prospectus | Jun 7, 2021 | — |
| S-1/A | Amended registration statement | Jun 7, 2021 | — |
| S-1/A | Amended registration statement | Jun 3, 2021 | — |
| FWP | Free writing prospectus | May 28, 2021 | — |
| S-1/A | Amended registration statement | May 25, 2021 | — |
| S-1 | Registration statement | May 10, 2021 | — |
Showing 23 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ALZN (Nasdaq)
- Fiscal year ends
- April 30
- Incorporated in
- DE
- Headquarters
- Atlanta, GA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1677077
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.